B3 Lesions of Breast: Two Year Retrospective Analysis of 4478 Cases Carried out in a Single Centre in the UK B3 breast lesions

Zaibun Nisa (1), Sheena Bajaj (2)
(1) Department of Histopathologist, Queen’s Hospital, Romford, London, UK, United Kingdom,
(2) Department of Histopathologist, Queen’s Hospital, Romford, London, UK, United Kingdom

Abstract

Background: B3 category mainly consists of lesions that provide benign histology on core biopsy, but either are known to show heterogeneity or have increased risk of associated malignancy. However, the level of risk is very different for different entities. All the cases should be looked for atypia.


The objective of this study is to compare various B3 lesions in two audits, to calculate the median rate and upgrade rates (the rate at which they turn into malignancy on subsequent excision) for different B3 lesions and to compare them with the national standards and published literature. The study aims to see whether vacuum assisted excision or surgical excision has been done in such lesions.


Methods: This is a retrospective study and encompasses two audits done in 2017-18 and 2020-21 at Queen's hospital, Barking, Havering and Redbridge NHS trust. A total of 4478 cases were reviewed and 206 cases were graded as B3 on core biopsy.


Results: Overall, 113 cases were graded as B3 in 2020-21 and 93 cases in 2017-18 giving the median rate of 5% and the overall upgrade rate of 12%. Intraductal papilloma was the most commonly seen lesion in both audits. Also, 31 cases underwent vacuum assisted excision and 62 cases underwent surgical excision, with 38 cases not undergoing further excision.


Conclusion: The median rate was within the 'preferred median rate'- 4.5-8.5% and the upgrade rate was comparable (16.57%) with those of National Breast Cancer screening audit, 2016-2019. The type of excision for various lesions was in line with the criteria stated by the Royal College of Pathologists. The lesions which were not excised did not turn into malignancy on follow-up.

Full text article

Generated from XML file

References

Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD; UK National Coordinating Commmittee for Breast Screening Pathology; European Commission Working Group on Breast Screening Pathology. Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol. 2004 Sep;57(9):897-902.

doi: 10.1136/jcp.2003.010983.

Pinder SE, Shaaban A, Deb R, Desai A, Gandhi A, Lee AHS, Pain S, Wilkinson L, Sharma N. NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol. 2018 Aug;73(8):682-692. doi: 10.1016/j.crad.2018.04.004.

Girardi V, Guaragni M, Ruzzenenti N, Palmieri F, Fogazzi G, Cozzi A et al. B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies. Cancers (Basel). 2021 Oct 29;13(21):5443.

doi: 10.3390/cancers13215443.

National breast screening pathology audit, updated September 2021. Available from: https://www.gov.uk/government/publications/national-breast-screening-pathology-audit/national-breast-screening-pathology-audit

Sharma N, Cornford E, Cheung S, Price H, Kearins O. The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England. Clin Radiol. 2021 Jun;76(6):470.e23-470.e29.

doi: 10.1016/j.crad.2021.01.021.

Yu YH, Liang C, Yuan XZ. Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review. Breast Cancer Res Treat. 2010 Apr;120(2):469-79.

doi: 10.1007/s10549-010-0750-1.

Verschuur-Maes AH, van Deurzen CH, Monninkhof EM, van Diest PJ. Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review. Ann Surg. 2012 Feb;255(2):259-65.

doi: 10.1097/SLA.0b013e318233523f.

Rakha EA, Lee AH, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer. 2011 Sep 15;129(6):1417-24.

doi: 10.1002/ijc.25801. Epub 2011 Feb 11. PMID: 21128240.

Bianchi S, Bendinelli B, Saladino V, et al. Non-malignant breast papillary lesions—B3 diagnosed on ultrasound-guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature. Pathol Oncol Res. 2015 Jul;21(3):535-46.

doi: 10.1007/s12253-014-9882-7.

El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology. 2008 Dec;53(6):650-7.

doi: 10.1111/j.1365-2559.2008.03158.x.

Abdulcadir D, Nori J, Meattini I, et al. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature. Eur J Surg Oncol. 2014 Jul;40(7):859-64.

doi: 10.1016/j.ejso.2014.02.222.

Authors

Zaibun Nisa
dr.zaibunnisa@outlook.com (Primary Contact)
Sheena Bajaj
1.
Nisa Z, Bajaj S. B3 Lesions of Breast: Two Year Retrospective Analysis of 4478 Cases Carried out in a Single Centre in the UK: B3 breast lesions. Arch Breast Cancer [Internet]. 2022 Nov. 6 [cited 2024 Apr. 14];10(1):81-5. Available from: https://archbreastcancer.com/index.php/abc/article/view/633

Article Details